Overview

Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)

Status:
Completed
Trial end date:
2019-01-24
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and effectiveness of different injection techniques of Collagenase Clostridium Histolyticum (CCH) for the treatment of adult women with mild, moderate or severe Edematous Fibrosclerotic Panniculopathy (commonly known as Cellulite).
Phase:
Phase 2
Details
Lead Sponsor:
Endo Pharmaceuticals